Literature DB >> 21425696

Pharmacological developments obtained from marine natural products and current pipeline perspective.

Elkin Galeano1, Jhon J Rojas, Alejandro Martínez.   

Abstract

Marine organisms represent a new extensive source for bioactive molecules. They have the potential to provide new therapeutic alternatives to treat human diseases. In this paper, we describe and discuss a variety of isolated and semisynthetic molecules obtained from marine sources. These compounds are in phase II, phase III and at the commercialization stage of new drug development. A description of the mechanism of action, dosage used and side effects are also reported. The positive results obtained from these studies have triggered the development of new studies to evaluate the prospects for utilization of marine organisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21425696

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  3 in total

1.  Antiparasitic bromotyrosine derivatives from the marine sponge Verongula rigida.

Authors:  Elkin Galeano; Olivier P Thomas; Sara Robledo; Diana Munoz; Alejandro Martinez
Journal:  Mar Drugs       Date:  2011-10-14       Impact factor: 6.085

Review 2.  Synthetic strategies to terpene quinones/hydroquinones.

Authors:  Marina Gordaliza
Journal:  Mar Drugs       Date:  2012-02-14       Impact factor: 6.085

Review 3.  Biological Activity of Recently Discovered Halogenated Marine Natural Products.

Authors:  Gordon W Gribble
Journal:  Mar Drugs       Date:  2015-06-30       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.